Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares Outstanding
Ratios

Cavitation Technologies (CVAT) Shares Outstanding (2016 - 2025)

Cavitation Technologies' Shares Outstanding history spans 15 years, with the latest figure at $309.7 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 8.95% to $309.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $309.7 million, a 8.95% increase, with the full-year FY2025 number at $289.2 million, up 1.71% from a year prior.
  • Shares Outstanding hit $309.7 million in Q4 2025 for Cavitation Technologies, up from $289.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for CVAT hit a ceiling of $309.7 million in Q4 2025 and a floor of $197.0 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $271.4 million across 5 years, with a median of $284.3 million in 2023.
  • Biggest five-year swings in Shares Outstanding: changed 0.0% in 2021 and later skyrocketed 38.43% in 2022.
  • Tracing CVAT's Shares Outstanding over 5 years: stood at $254.7 million in 2021, then grew by 8.64% to $276.7 million in 2022, then grew by 2.74% to $284.3 million in 2023, then changed by 0.0% to $284.3 million in 2024, then increased by 8.95% to $309.7 million in 2025.
  • Business Quant data shows Shares Outstanding for CVAT at $309.7 million in Q4 2025, $289.2 million in Q3 2025, and $289.2 million in Q2 2025.